↓ Skip to main content

Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results

Overview of attention for article published in Clinical Pharmacology & Therapeutics, July 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results
Published in
Clinical Pharmacology & Therapeutics, July 2023
DOI 10.1002/cpt.2983
Pubmed ID
Authors

HoJin Shin, Shirley V. Wang, Dae Hyun Kim, Ethan Alt, Mufaddal Mahesri, Lily G. Bessette, Sebastian Schneeweiss, Mehdi Najafzadeh

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 12%
Student > Ph. D. Student 1 6%
Unspecified 1 6%
Researcher 1 6%
Other 1 6%
Other 0 0%
Unknown 11 65%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 18%
Unspecified 1 6%
Nursing and Health Professions 1 6%
Medicine and Dentistry 1 6%
Unknown 11 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2023.
All research outputs
#17,335,712
of 25,440,205 outputs
Outputs from Clinical Pharmacology & Therapeutics
#3,618
of 4,505 outputs
Outputs of similar age
#208,575
of 365,339 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#27
of 52 outputs
Altmetric has tracked 25,440,205 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,505 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,339 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.